Universal-Beteiligungs- und Servicegesellschaft
CTMX icon

Universal-Beteiligungs- und Servicegesellschaft’s CytomX Therapeutics CTMX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Buy
50,529
+23,869
+90% +$91.1K ﹤0.01% 2036
2026
Q1 		$125K Buy
+26,660
New +$135K ﹤0.01% 2010
2025
Q2 		– Sell
-97,123
Closed -$61.8K – 2026
2025
Q1 		$61.8K Buy
+97,123
New +$75.3K ﹤0.01% 1965

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's CTMX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its CytomX Therapeutics (CTMX) stake by 90% in Q2 2026, buying an estimated $91.1K and bringing the position to 50,529 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #2036.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in CTMX in Q1 2025 and has held it in 3 quarters since. 178 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 50,529 shares of CytomX Therapeutics worth $189K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 23,869 CytomX Therapeutics shares in Q2 2026, an estimated $91.1K.
  • CytomX Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #2036 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in CytomX Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 178 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.